Toru Shinzato

2.2k citations
48 papers · 1.7k indexed · h-index 21

Toru Shinzato

46 papers receiving 1.6k citations

Peers

Toru Shinzato
Comparison fields: 5 of 113
  • Nephrology 908
  • Clinical Biochemistry 419
  • Emergency Medical Services 161
  • Hematology 206
  • Endocrinology, Diabetes and Metabolism 228
Replace Yoshihei Hirasawa with:
Yoshihei Hirasawa Japan
Zongpei Jiang China
Tsutomu Sanaka Japan
Philippe Zaoui France
Eileen N. Ellis United States
A Naso Italy
C. Wanner Germany
Aleksandar Sikole North Macedonia
Hiroyuki Terawaki Japan
Tatsuo Yamamoto Japan
Toru Shinzato relative to Yoshihei Hirasawa Japan Yoshihei Hirasawa's profile →
Citations per field
00.5×2.8×
Yoshihei Hirasawa · 1×
Citations per year

Countries citing papers authored by Toru Shinzato

Since Specialization
Citations

This map shows the geographic impact of Toru Shinzato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toru Shinzato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toru Shinzato more than expected).

Fields of papers citing papers by Toru Shinzato

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toru Shinzato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toru Shinzato. The network helps show where Toru Shinzato may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Toru Shinzato, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Toru Shinzato Line = papers co-authored together Toru Shinzato links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20150
2 200718
3 20026
4 2001287
5 200146
6 199916
7 19986
8 199814
9 1998120
10 19971
11 19964
12 199623
13 199626
14 199670
15 19960
16 19955
17 199555
18 199419
19 19941
20
Some new aryl-sydnones: effects on murine tumours.
199228

About Toru Shinzato

Toru Shinzato is a scholar working on Nephrology, Clinical Biochemistry and Hematology, having authored 48 papers that have together received 1.7k indexed citations. Recurring topics across this work include Dialysis and Renal Disease Management (21 papers), Muscle and Compartmental Disorders (7 papers), Acute Kidney Injury Research (5 papers), Iron Metabolism and Disorders (5 papers), Advanced Glycation End Products research (5 papers), Immune Cell Function and Interaction (4 papers), Glycosylation and Glycoproteins Research (3 papers) and Chronic Kidney Disease and Diabetes (3 papers). The work is most often cited by research in Nephrology (908 citations), Clinical Biochemistry (419 citations) and Emergency Medical Services (161 citations). Toru Shinzato has collaborated with scholars based in Japan, Brazil and United States. Frequent co-authors include Kenji Maeda, Hiroko Odani, Yoshihiro Matsumoto, Jun Usami, Shigeru Nakai, Hitoo Iwase, Yoshinari Yasuda, Mami Takahashi, Ichiro Takai and Yoshiyuki Hiki. Their work appears in journals such as Kidney International, Artificial Organs, ASAIO Journal, Nephrology Dialysis Transplantation and Biochemical and Biophysical Research Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026